News | May 05, 2015

Strategic Radiology Takes Unified Stance Against New USPSTF Guidelines

Independent radiology physician coalition joins other groups in advocating for mammography screening beginning at age 40

Strategic Radiology, USPSTF, mammography screening, guidelines

May 4, 2015 — In response to the proposed mammography guidelines from the U.S. Preventive Services Task Force (USPSTF), Strategic Radiology (SR) recommends regular screening mammography for women beginning at age 40 in order to reduce breast cancer mortality. SR joins other organizations — including the American Congress of Obstetricians and Gynecologists (ACOG), the American College Of Surgeons, Susan G. Komen for the Cure, American Cancer Society (ACS), American College of Radiology (ACR) and Society of Breast Imaging (SBI) — in speaking out against the USPSTF guidelines.

“As the nation’s largest coalition of independent radiology group practices, Strategic Radiology felt it was imperative to step up and speak out regarding the USPSTF’s draft questioning the value of annual screening mammograms for women starting at age 40,” said Arl Van Moore, Jr, M.D., FACR, CEO of SR. “We stand united with the healthcare industry’s leading associations, including the American College of Radiology, in the current screening mammography guidelines that have saved countless lives since the inception of this vital breast imaging technology.”

The proposed guidelines from the USPSTF draft create the possibility of insurance companies to restrict mammogram coverage for most women under age 50, even as the task force acknowledges that not screening such women will result in the deaths of women whose lives could have been otherwise saved. The existing guidelines would give the exam for women under age 50 a letter grade of “C,” meaning insurance companies would no longer be required to cover the procedure under the terms of the Affordable Care Act. The burden of uninsured mammograms would fall particularly heavily on women who are economically disadvantaged.

Furthermore, all women would be burdened by any decision to restrict insurance to mammograms only every other year. Analysis of the task force’s guidelines suggests that up to an additional 6,500 women will die from breast cancer annually if its recommendations are fully followed.

The task force’s recommendation that mammograms be performed only every other year for women ages 50 and over may potentially encourage a rollback of current law mandating insurance coverage for annual exams. Although the task force agrees that screening can be more effective for women in their 40s who have a family history, they do not take into account the fact that 75 percent of women ages 40 to 49 diagnosed with breast cancer have no family history. As with the task force’s earlier guidelines, SR believes this update will likely cause widespread confusion among women in regard to the age at which screening mammography should begin, as well as the frequency of exams.

“It is very disturbing that this flawed report will cause confusion about what are already proven benefits for women 40-plus years old,” said Matthew Gromet, JD, M.D., FACR, chief of mammography of Charlotte Radiology. “This will cause some women to skip their annual mammograms, which will lead to unnecessary deaths as well as discovery of cancers in later clinical stages, complicating their treatment.”

As an organization consisting of more than 1,300 physicians, SR believes the guidelines are fundamentally flawed and not supported by scientific evidence. The panel did not include breast cancer care or screening experts, but rather relied upon computer models in place of actual research.

Since mammography screening began at a national level over two decades ago, annual breast cancer mortality rates have declined by 30 percent. Screening mammography often allows for earlier detection of breast cancer, which in turn affords women more treatment options, reduced surgeries, better cosmetic outcomes, and may eliminate the need for harsh chemotherapy. The breast imaging specialists serving in SR’s 21 member groups strongly agree with industry experts that breast cancer therapy is most effective when the disease is caught early.

SR urges American healthcare consumers, particularly women, to let the panel know how they feel about the proposed recommendations and the possibility of losing insurance coverage for mammograms. Comments on the draft will be accepted until May 18.

Other healthcare industry leaders are also speaking out:

“Just as breast cancer treatment has evolved from the ‘one size fits all’ approach of past years to more personalized and targeted therapies, breast cancer screening is evolving as well, and any screening recommendations must account for an assessment of an individual’s risk,” said Susan G. Komen President and CEO Judith A. Salerno, M.D., MS. “It is becoming increasingly clear that age-based recommendations cannot be our only standard.”

“The USPSTF limited its consideration to studies that underestimate the lifesaving benefit of regular screening and greatly inflate overdiagnosis claims,” said Barbara Monsees, M.D., FACR, chair of the ACR Breast Imaging Commission. “They ignored more modern studies that have shown much greater benefit. These limitations result in the misrepresentation of the real trade offs that women and healthcare providers need to know about in order to make good decisions about screening. They also ignored the demonstrated views of American women on screening. Unfortunately, these recommendations will only add to confusion that is placing women at risk.”

For more information: www.strategicradiology.org

Related Content

Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Why guidelines aren't just for patients

Image courtesy of Eizo

Feature | Women's Health | October 04, 2017 | By Stamatia Destounis, M.D., FACR
Over the years, significant progress has been made educating women, men and families about breast cancer — the pink...
Overlay Init